Cargando…
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
BACKGROUND: Many commercial assays, of different designs, detecting SARS-CoV-2-specific antibodies exist but with little experience with them. OBJECTIVES: The aim of this study was to compare the performance of assays detecting IgG or total antibodies to N or S antigens, validated for routine use in...
Autores principales: | Trabaud, Mary-Anne, Icard, Vinca, Milon, Marie-Paule, Bal, Antonin, Lina, Bruno, Escuret, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476603/ https://www.ncbi.nlm.nih.gov/pubmed/32942137 http://dx.doi.org/10.1016/j.jcv.2020.104613 |
Ejemplares similares
-
Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research
por: Low, Swee Ling, et al.
Publicado: (2021) -
Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays
por: Hönemann, Mario, et al.
Publicado: (2021) -
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
por: Saker, Kahina, et al.
Publicado: (2022) -
Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
por: Jääskeläinen, Anne J, et al.
Publicado: (2020) -
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
por: Bal, Antonin, et al.
Publicado: (2021)